Corpus Intelligence IC Memo — CHRISTUS TRINITY MOTHER FRANCES REHA 2026-04-26 08:50 UTC
IC Memo — CHRISTUS TRINITY MOTHER FRANCES REHA
Investment Committee Memorandum | TX | 94 beds | Grade D | EBITDA uplift $2.7M
🛡️ Public data only — no PHI permitted on this instance.
Investment Committee Memorandum

CHRISTUS TRINITY MOTHER FRANCES REHA

CCN 453056 | SMITH, TX | 94 beds | April 26, 2026
EBITDA BridgeData Room
D
Investability

1. Target Overview & Investment Thesis

CHRISTUS TRINITY MOTHER FRANCES REHA is a 94-bed community hospital in SMITH, TX with $37.2M in net patient revenue and a 22.0% operating margin. The hospital serves a payer mix of 62.0% Medicare, 0.0% Medicaid, and 38.0% commercial.

Thesis: Turnaround. Our ML models identify $2.7M in annual EBITDA improvement potential from RCM optimization across 5 levers, lifting margin from 22.0% to 29.4% (+736bps).

Net Revenue HCRIS$37.2M
Current EBITDA COMPUTED$8.2M
Operating Margin COMPUTED22.0%
Occupancy HCRIS72.5%
Revenue / Bed COMPUTED$396K
Net-to-Gross HCRIS68.6%
Distress Probability MLnan%

2. Market Context & Competitive Position

583
TX Hospitals
-0.7%
State Median Margin
199
Comparable Hospitals

TX has 583 Medicare-certified hospitals with a median operating margin of -0.7%. The target's margin of 22.0% places it above the state median. Among 199 size-comparable peers (47-188 beds), the median margin is 2.4%. The target performs in line with or above peers.

3. RCM Performance Analysis — Comparable Hospitals

Comps selected by bed count (47-188), prioritizing same-state peers. 199 hospitals in the comp set.

HospitalStateBedsRevenueMargin
CHRISTUS TRINITY MOTHER FRANCE (Target)TX94$37.2M22.0%
ROUND ROCK HOSPITALTX165$681.4M8.7%
THE HEART HOSPITAL BAYLOR PLANTX109$464.6M25.7%
COVENANT CHILDRENS HOSPITALTX181$410.3M15.5%
COLLEGE STATION HOSPITALTX135$397.7M-0.9%
CHILDRENS HOSPITAL OF SAN ANTOTX174$376.5M-2.8%
DECATUR COMMUNITY HOSPITALTX81$361.0M-15.5%
CHILDRENS MEDICAL CENTER OF PLTX72$336.7M20.9%
MEDICAL CITY MCKINNEYTX166$302.5M-0.4%

4. Predicted Improvement Opportunities

Improvement targets set at P75 of comparable peers with 60% gap closure assumption. Coefficients calibrated to published research bands. Total EBITDA uplift: $2.7M (736bps margin improvement).

LeverCurrentTargetEBITDA ImpactMarginRamp
Net Collection Rate93.5%97.0%$781K+210bp18mo
Cost to Collect4.5%2.5%$744K+200bp12mo
Denial Rate Reduction12.0%6.5%$737K+198bp12mo
A/R Days Reduction5200.0%3800.0%$453K+122bp9mo
Clean Claim Rate88.0%96.0%$24K+6bp6mo

5. EBITDA Bridge

Net Collection Rate
$781K
Cost to Collect
$744K
Denial Rate Reduction
$737K
A/R Days Reduction
$453K
Clean Claim Rate
$24K
Total EBITDA Uplift$2.7M
Current EBITDA$8.2M
+ RCM Uplift+$2.7M
Pro Forma EBITDA$10.9M
Current Margin22.0%
Pro Forma Margin29.4%
WC Released (1x)$1.4M

6. Returns Analysis — Scenario Matrix

5-year hold, 5.5x leverage, 3% organic growth, 10%/yr debt paydown. Base case uses 100% of predicted RCM uplift. Bull case: 130% uplift at lower entry. Bear case: 50% uplift at higher entry.

ScenarioEntryExitEquity InEquity OutMOICIRR
Base Case10.0x10.0x$12.6M$81.4M6.46x45.2%
Base (11x exit)10.0x11.0x$12.6M$93.6M7.43x49.4%
Bull Case9.0x11.0x$11.3M$106.7M9.42x56.6%
Bull (12x exit)9.0x12.0x$11.3M$119.8M10.57x60.2%
Bear Case11.0x10.0x$13.9M$63.6M4.59x35.6%
Bear (11x exit)11.0x11.0x$13.9M$74.5M5.37x40.0%

7. Key Risks & Mitigants

SeverityRisk FactorMitigant
MediumHeavy Medicare dependenceMedicare comprises 62.0% of days; rate updates may lag inflation. Mitigant: CDI/CMI lever directly increases Medicare reimbursement

8. Data Sources & Methodology Appendix

Data Sources

  • CMS HCRIS Cost Reports (Medicare-certified hospitals)
  • CMS Medicare Utilization (DRG-level volumes)
  • CMS Chronic Conditions (county-level disease prevalence)
  • HCRIS multi-year trend data (financial time series)

Comparable Selection

  • 199 hospitals with 47-188 beds
  • Same-state prioritization (n=200)
  • Comp margins: P25=-10.7% / P50=2.4% / P75=11.7%

Bridge Methodology

  • Targets: P75 of comparable peers (60% gap closure)
  • Denial: avoidable share = 35% of delta × NPR
  • AR: bad debt coefficient = $0.65 per day per $1K NPR
  • NCR: 60% coefficient on collection rate improvement
  • CDI: 0.75% of Medicare revenue per 0.01 CMI point

Returns Assumptions

  • Leverage: 5.5x entry (84.6% debt / 15.4% equity)
  • Organic growth: 3% annual EBITDA growth
  • Debt paydown: 10% of principal per year
  • Hold period: 5 years

Generated by SeekingChartis on April 26, 2026. All predictions use public data only. Confidence intervals calibrated via split conformal prediction (90% coverage target). This memo is for informational purposes and does not constitute investment advice.